Phase 2 Clinical Activity of Crizotinib in ALCL
|Title:||Phase 2 Clinical Activity of Crizotinib in ALCL|
This graph shows the phase 2 clinical activity of the targeted drug crizotinib in patients with anaplastic large cell lymphoma (ALCL).
This image is part of the NCI Annual Plan and Budget Proposal FY 2020 collection.
See also www.cancer.gov/about-nci/budget/plan.
Cancer Types -- Lymphoma
Infographics -- Health
|Type:||Color, Illustration (JPEG format)|
|Source:||National Cancer Institute (NCI)|
|Date Created:||September 24, 2018|
|Date Added:||September 24, 2018|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|